[return to list
W.  Michael  Scheld
Degree(s): M.D.
Graduate School: Cornell University, Medical College
Primary Appointment: Professor of Medicine, Infectious Diseases and International Health
Research Interests:
Molecular mechanisms of bacterial pathogenesis, sepsis/septic shock, adenosine receptors, inflammation, innate immunity, anthrax, vaccines

Email Address: wms@virginia.edu


Research Description

The main focus of the Scheld research laboratory is on the pathogenesis and pathophysiology of infections of the central nervous system (CNS), particularly meningitis. These studies explore the complex bacterial/host relationship responsible for alterations in critical homeostatic mechanisms of the CNS including neuronal injury and death, altered permeability of the blood-brain barrier (BBB) at the level of the cerebromicrovascular endothelium, and induction of subarachnoid space inflammation. Bacterial cell surface constituents including capsule, cell wall, outer membrane vesicles, and lipopolysaccharide have been the focus of previous experiments. Current studies are focusing on the role of reactive oxygen and nitrogen intermediates (particularly nitric oxide and its metabolites) in altered CNS homeostasis. The studies utilize cerebromicrovascular ndothelial cells in tissue culture as well as animal models of meningitis to elucidate the mechanisms responsible for CNS injury. Current experiments examine leukocyte-endothelial interactions at the level of the blood-brain barrier with an emphasis on ICAM-1, the correlation of cerebrospinal fluid (CSF) nitrite concentrations (a metabolite of nitric oxide) with altered CNS homeostasis, detection of upregulation of inducible nitric oxide synthase in situ including molecular techniques for the detection of messenger RNA, and interventions designed to reduce subarachnoid space inflammation and improve the neurologic outcome from this infection.


Selected Publications
  • Sullivan GW, Fang G, Linden J, Scheld WM. A2a adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis. J Infect Dis. 2004; May 15;189(10):1897-1904.
  • Cohen SB, Gill SS, Bae GS, Leo BM, Scheld WM, and Diduch DR. Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist. J Orthope Res. 2004 March;22(2):427-35.
  • Sullivan GW, Rieger JM, Scheld WM, Macdonald TL, Linden J. Ccyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexl adensoine A2A receptor agonists. Br J Exp Pharmacol 2001;132:1017-26.
  • Hogan CJ, Fang GD, Scheld WM, Linden J, Diduch DR. Inhibiting the inflammatory response in joint sepsis. Arthroscopy. 2001 Mar;17(3):311-315
  • PubMed Listings for this Faculty Member

  • Intranet Profile
    [To add/update Intranet profile information, read these instructions.]

    Contact Information
      Office Address: PO Box 801342, School of Medicine, 
      Office Phone: +1 434-924-5991
      Fax Phone: +1 434-924-2885
      Home Phone: +1 434-973-1041

    (Find Out How to Update Your Faculty Profile)